Back to search

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

Data up to Jan 2025

Published2008
Citations160
References35

Total Citations Per Year

Abstract

References (35)

Human papillomavirus and cervical cancer

2007 • 2,789 citations

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,829 citations

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

2006 • 1,766 citations

Centers for Disease Control and Prevention (CDC) : Advisory Committee on Immunization Practices (ACIP) : Quadrivalent human papillomavirus vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,644 citations

A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

2002 • 1,570 citations

Chapter 2: The burden of HPV-related cancers

2006 • 1,374 citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

2007 • 1,287 citations

The Pap Test and Bethesda 2014

2015 • 1,122 citations

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

2007 • 831 citations

Carcinogenicity of human papillomaviruses

2005 • 678 citations

Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus

1999 • 659 citations

Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

2007 • 652 citations

Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica

2000 • 611 citations

HPV DNA Testing in Cervical Cancer Screening

2000 • 549 citations

Novel Short-Fragment PCR Assay for Highly Sensitive Broad-Spectrum Detection of Anogenital Human Papillomaviruses

1998 • 516 citations

Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections

2008 • 505 citations

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

2006 • 453 citations

Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide

2006 • 411 citations

Epidemiologic Profile of Type‐Specific Human Papillomavirus Infection and Cervical Neoplasia in Guanacaste, Costa Rica

2005 • 377 citations

Chapter 8: Screening for cervical cancer in developing countries

2006 • 341 citations

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

2008 • 334 citations

International trends in incidence of cervical cancer: II. Squamous-cell carcinoma

2000 • 283 citations

An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

2001 • 249 citations

HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

2001 • 247 citations

Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas

1996 • 247 citations

Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project

1997 • 205 citations

Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR

2006 • 157 citations

Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women

2006 • 114 citations

Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica

2004 • 83 citations

Comparison of the SPF 10 -LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica

2007 • 76 citations

A Comparison of a Prototype PCR Assay and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus DNA in Women With Equivocal or Mildly Abnormal Papanicolaou Smears

2005 • 76 citations

A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.

2003 • 71 citations

Introducing human papillomavirus vaccines—questions remain

2008 • 28 citations

Epidemiology of Genital Chlamydia trachomatis Infection Among Young Women in Costa Rica

2008 • 22 citations

A Comparison of a Prototype PCR Assay and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus DNA in Women With Equivocal or Mildly Abnormal Papanicolaou Smears

2005 • 11 citations

Cited By (0)

No citing papers found in database

Rationale and design of a community-based double-blind randomized clinical trial of an… (2008) – Vaccine | Metascience Observatory Explorer